Adrenomedullin (1-50), rat是一种由50个氨基酸组成的多肽,能够通过激活降钙素基因相关肽1(CGRP1)受体诱导选择性动脉血管舒张。
Sample solution is provided at 25 µL, 10mM.
Adrenomedullin (1-50), rat is a 50-amino acid polypeptide that induces selective arterial vasodilation by activating the calcitonin gene-related peptide 1 (CGRP1) receptor[1]. In vivo, Adrenomedullin (1-50), rat can regulate hypoxic pulmonary hypertension by promoting the production of nitric oxide (NO) and hydrogen sulfide (H2S) and reducing pulmonary vascular remodeling in hypoxic rats[2, 3].
In vivo, intrathecal administration of rat Adrenomedullin (1-50) (20μg) for 3 days in a rat model of mechanical pain induced mechanical allodynia, increased the expression levels of pERK and nNOS in the spinal dorsal horn, increased the expression levels of Iba1 and GFAP in the spinal cord, and upregulated TRPV1 expression in dorsal root ganglion (DRG) cultures[4].
References:
[1] Berthiaume N, Claing A, Cadieux A, et al. Rat adrenomedullin induces a selective arterial vasodilation via CGRP1 receptors in the double-perfused mesenteric bed of the rat[J]. Canadian journal of physiology and pharmacology, 1995, 73(7): 1080-1083.
[2] Vadivel A, Abozaid S, van Haaften T, et al. Adrenomedullin promotes lung angiogenesis, alveolar development, and repair[J]. American journal of respiratory cell and molecular biology, 2010, 43(2): 152-160.
[3] Matsui H, Shimosawa T, Itakura K, et al. Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia[J]. Circulation, 2004, 109(18): 2246-2251.
[4] Huang H, Wang M, Hong Y. Intrathecal administration of adrenomedullin induces mechanical allodynia and neurochemical changes in spinal cord and DRG[J]. Neuroscience Letters, 2019, 690: 196-201.
Adrenomedullin (1-50), rat是一种由50个氨基酸组成的多肽,能够通过激活降钙素基因相关肽1(CGRP1)受体诱导选择性动脉血管舒张[1]。Adrenomedullin (1-50), rat在体内能够调节低氧性肺动脉高压,通过促进一氧化氮(NO)和硫化氢(H2S)的生成,减轻缺氧大鼠的肺血管结构重塑[2, 3]。
在体内,Adrenomedullin (1-50), rat(20μg)通过鞘内注射给药处理机械性疼痛模型大鼠3天,诱导产生了机械性异常性疼痛,增加了脊髓背角中pERK和nNOS的表达水平,增加了脊髓中Iba1和GFAP的表达水平,提高了背根神经节(DRG)培养物中TRPV1的表达[4]。
| Animal experiment [1]: | |
Animal models | Sprague-Dawley rats |
Preparation Method | Rats was injected with sodium pentobarbital (50mg/kg, i.p.). A small slit was cut in the dura mater overlying the atlanto-occipital membrane of rats. A PE-10 tubing was inserted into the intrathecal space with its tip being positioned at the L4-L5 segments of the spinal cord. Then the rats were housed in dividually and allowed to recover for 1 week. The location of in trathecal catheter tip was confirmed by injecting lidocaine (200μg/10μL) and this procedure caused a motor paralysis of the lower limbs. Adrenomedullin (1-50) (AM1-50) (20μg) or AM1-50+AM22-52 (20μg) was administered intrathecally (i.t.) once per day for 3days. PWT in response to mechanical stimulus was tested after the drug administration on days 1, 2 and 3 (up to day 5). Animals were sacrificed by decapitation. Dorsal root ganglion (DRG) at C2-L6 were dissected and collected under sterile technique. |
Dosage form | 20μg; 3 days; intrathecally (i.t.) |
Applications | Intrathecal administration of Adrenomedullin (1-50) induced mechanical allodynia. Adrenomedullin (1-50) increased pERK and nNOS in spinal dorsal horn. Adrenomedullin (1-50) increased expression of Iba1 and GFAP in spinal cord. Application of Adrenomedullin (1-50) to DRG cultures increased expression of TRPV1. |
References: | |
| Cas No. | SDF | ||
| Canonical SMILES | Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 (Disulfide bridge: Cys14-Cys19) | ||
| 分子式 | C248H381N77O75S5 | 分子量 | 5729.5 |
| 溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 174.5 μL | 872.7 μL | 1.7454 mL |
| 5 mM | 34.9 μL | 174.5 μL | 349.1 μL |
| 10 mM | 17.5 μL | 87.3 μL | 174.5 μL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















